Hexokinase 2 is a determinant of neuroblastoma metastasis

Generation and Characterization of Novel Local and Metastatic Human Neuroblastoma Variants

(2015) Ido Nevo et al.   NEOPLASIA

The role played by the microenvironment in site-specific metastasis

(2013) Anat Klein-Goldberg et al.   CANCER LETTERS

The metastatic microenvironment: Lung-derived factors control the viability of neuroblastoma lung metastasis

(2013) Shelly Maman et al.   INTERNATIONAL JOURNAL OF CANCER

Lung-Residing Metastatic and Dormant Neuroblastoma Cells

(2011) Liat Edry Botzer et al.   AMERICAN JOURNAL OF PATHOLOGY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

The bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracil

(2011) María Sánchez-Aragó et al.   Journal of Translational Medicine

3-Bromopyruvate induces necrotic cell death in sensitive melanoma cell lines

(2010) J.-Z. Qin et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Stable RNA interference of hexokinase II gene inhibits human colon cancer LoVo cell growth in vitro and in vivo

(2010) Qiuping Peng et al.   CANCER BIOLOGY & THERAPY

Neuroblastoma: Therapeutic strategies for a clinical enigma

(2010) Shakeel Modak et al.   CANCER TREATMENT REVIEWS

Foreword

(2010) Giustino Varrassi   CLINICAL DRUG INVESTIGATION

Identification of Multiple Hypoxia Signatures in Neuroblastoma Cell Lines byl1-l2Regularization and Data Reduction

(2010) Paolo Fardin et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

The sweet side of HIF

(2010) Volker H. Haase   KIDNEY INTERNATIONAL

Neuroblastoma: contemporary management

(2009) D Mullassery et al.   Archives of Disease in Childhood-Education and Practice Edition

Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate

(2009) Zhao Chen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

The Metastatic Process: Methodological Advances and Pharmacological Challenges

(2009) Antonio Mazzocca et al.   CURRENT MEDICINAL CHEMISTRY

Metabolic Targeting of Cancers: From Molecular Mechanisms to Therapeutic Strategies

(2009) Huaming Sheng et al.   CURRENT MEDICINAL CHEMISTRY

HIF-1α Modulates Energy Metabolism in Cancer Cells by Inducing Over-Expression of Specific Glycolytic Isoforms

(2009) Alvaro Marin-Hernandez et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation

(2009) L A Pradelli et al.   ONCOGENE

Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-d-glucose positron emission tomography

(2008) Bishnuhari Paudyal et al.   CANCER SCIENCE

Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer

(2008) Manon Buijs et al.   INVESTIGATIONAL NEW DRUGS

Hexokinase-2 bound to mitochondria: Cancer's stygian link to the “Warburg effect” and a pivotal target for effective therapy

(2008) Saroj P. Mathupala et al.   SEMINARS IN CANCER BIOLOGY